YOLFTbeta
08

LabGenomics Co. Ltd

084650 · KQ · Healthcare / Healthcare Providers & Services

1,985.00KRW+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close1,985.00
Open1,972.00
Day Range1,972.00 – 2,015.00
52-Week Range2,490.00 – 12,725.00
Volume40.53K
Market Cap39.79B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta-0.73
50-Day Avg2,942.10
200-Day Avg5,705.95

About

LabGenomics Co., Ltd. engages in the research and development of biotechnology products in South Korea. It is also involved in the sale of diagnostic devices. The company was founded in 2002 and is based in Seongnam-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryHealthcare Providers & Services
  • CEOMr. Sung Hyun Chin
  • Employees228
  • HeadquartersKorea Bio Park Building, Seongnam, South Korea, 463-400, Korea
  • Websitehttp://www.labgenomics.co.kr

Leadership

  • Mr. Sung Hyun ChinChief Exec. Officer · b. 1968

Financials

Income Statement

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue23.20B23.59B24.06B24.81B27.54B33.18B119.48B202.41B144.77B71.08B85.90B88.16B
Growth (%)-+1.67%+1.98%+3.11%+11.02%+20.47%+260.14%+69.41%-28.47%-50.90%+20.85%+2.63%
Cost of Revenue11.91B12.27B13.30B15.34B18.10B19.79B47.73B77.00B48.01B40.72B54.49B57.52B
Gross Profit11.29B11.32B10.75B9.46B9.44B13.39B71.75B125.41B96.77B30.36B31.41B30.64B
Gross Margin48.64%48.00%44.70%38.15%34.27%40.36%60.05%61.96%66.84%42.71%36.56%34.76%
Operating Expense8.67B10.29B10.76B12.40B12.66B12.61B18.48B20.95B30.56B37.28B53.04B84.16B
Operating Income2.62B1.03B-8.48M-2.94B-3.23B775.78M53.27B104.46B66.21B-6.92B-21.63B-53.52B
Operating Margin11.28%4.38%-0.04%-11.84%-11.71%2.34%44.58%51.61%45.73%-9.74%-25.18%-60.70%
EBITDA--------67.93B3.72B-10.84B-44.22B
EBITDA Margin--------46.92%5.23%-12.63%-50.16%
Net Income2.42B1.63B723.51M-3.44B-3.97B962.42M42.77B83.85B48.40B-4.67B-23.80B-64.37B
Net Income Margin10.43%6.89%3.01%-13.85%-14.43%2.90%35.79%41.43%33.43%-6.58%-27.70%-73.02%
R&D107.17M102.47M350.58M350.58M---556.87M1.86B2.62B2.68B1.87B
R&D as % of Total Revenue0.46%0.43%1.46%1.41%---0.28%1.29%3.69%3.12%2.12%
Interest Expense000000223.80M208.03M573.97M4.95B5.51B5.73B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.19%0.10%0.40%6.97%6.41%6.50%

Balance Sheet

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets31.09B31.69B43.21B39.87B47.09B49.48B109.36B204.29B250.65B313.46B295.66B230.15B
Total Liabilities9.86B9.54B18.17B17.52B16.99B19.06B27.82B46.57B41.32B85.31B79.35B80.53B
Total Equity21.24B22.15B25.04B22.35B30.10B30.42B81.54B157.72B209.33B227.80B216.31B149.62B
Cash5.26B1.34B2.66M495.37M399.07M2.00B37.83B282.00K354.00K42.32B24.51B6.76B
Total Debt---11.24B9.35B9.88B4.20B-----
Net Debt-----7.30B---2.93B20.20B41.92B

Cash Flow

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow3.15B2.38B2.54B-1.06B608.03M3.19B46.37B65.36B69.87B2.42B-12.99B-30.54B
Investing Cash Flow-4.68B-5.02B-5.32B-8.40B-10.63B-85.82M-8.59B-26.06B-53.32B-116.60B-3.76B-
Financing Cash Flow5.24B-1.27B11.15B249.49M9.93B-1.49B-959.84M-7.19B11.45B57.65B-2.23B-
Capital Expenditure1.20B4.63B4.08B4.30B2.03B560.94M699.21M13.72B38.33B5.20B4.55B1.66B
Free Cash Flow------44.86B51.55B30.62B-9.02B-17.54B-32.20B
Dividends Paid--------3.32B0--
FCF to OCF------96.73%78.86%43.83%-372.58%134.99%105.45%
Dividend Paid to FCF--------10.83%0.00%--

Earnings

Report DateApr 24, 2015Aug 11, 2015Nov 12, 2015Feb 1, 2016May 11, 2016Aug 11, 2016Nov 14, 2016Feb 1, 2017May 15, 2017Aug 1, 2017Nov 14, 2017Feb 13, 2018May 14, 2018Aug 14, 2018Nov 14, 2018Feb 12, 2019May 14, 2019Aug 1, 2019Nov 12, 2019Feb 11, 2020May 15, 2020Aug 11, 2020Nov 15, 2020Feb 8, 2021May 17, 2021Aug 18, 2021Nov 1, 2021Feb 6, 2022Mar 31, 2022Jun 30, 2022Nov 14, 2022Feb 13, 2023Mar 31, 2023Jun 30, 2023Sep 30, 2023Mar 28, 2024Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------------------
EPS Actual22.8715.1233.5456.7149.9510.510.64-7.558.04-71.00-0.50-118.3313.84-48.93-14.45-95.406.5717.562.7715.5075.61792.00265.33130.49395.23653.47732.67711.802858.44315.36231.67-59.93277.14226.48-104.27-146.09-606.6315.24-182.48-828.76-362.02-986.68-234.42-2752.45-317.11-170.92
Surprise----------------------------------------------
TimingPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market-After-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hours---Pre-market---Pre-market----------

Key Statistics & Ratios

Market Cap39.79B
Enterprise Value69.27B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.57
Price / Book0.29
Revenue (TTM)187.01B
Gross Profit (TTM)124.89B
EBITDA103.01B
Profit Margin39.65%
Operating Margin53.17%
Return on Equity-920.44%
Return on Assets28.63%
Shares Outstanding9.08M
Shares Float27.17M
Beta-0.73
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20221×
100.00Dec 28, 2022
20211×
250.00Dec 29, 2021

Stock Splits

  • Aug 7, 20232:1
  • Mar 31, 2022959692:319897
  • Jun 15, 20162:1